In the dynamic landscape of pharmaceutical and healthcare industries, the relationship between the Medical Affairs function and commercial organizations is undergoing a significant transformation. The emergence of the desire for greater autonomy of the Medical Affairs function is closely tied to the growing trend of companies replacing traditional Medical Representatives with Medical Science Liaisons (MSLs). […]
Empowering Medical Affairs Autonomy Read More »
Entering the Japanese healthcare market can be a promising venture for overseas-based healthcare companies. However, it requires careful planning and a well-defined market entry strategy to navigate the complexities and cultural nuances. Below is a step-by-step guide to creating a market entry strategy for overseas-based healthcare companies targeting Japan: Market Research and Analysis: Conduct comprehensive
Japan market entry for healthcare companies Read More »
For much of the past decade, pharmaceutical companies have been pruning their teams and operations as regulatory and pricing pressures, patent expirations, and other challenges diminish profitability. Japan has felt the squeeze as well. In 2020, after its acquisition of Shire, Takeda set out to shed seven percent of its workforce, offering staff as young
Early retirement packages a rewarding next career step? Read More »
17F Yebisu Garden Place Tower, 4-20-3 Ebisu, Shibuya City, Tokyo, 150-6017
